Search Results - "CARITIS, Steve N"

Neonatal outcomes following preterm birth classified according to placental features by Catov, Janet M., PhD, MS, Scifres, Christina M., MD, Caritis, Steve N., MD, Bertolet, Marnie, PhD, Larkin, Jacob, MD, Parks, W. Tony, MD

“…Background Preterm birth has staggering health implications, and yet the causes of most cases are still unknown. Placental features have been understudied as…”
Get full text

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial by Costantine, Maged M., MD, Cleary, Kirsten, MD, Hebert, Mary F., PharmD, FCCP, Ahmed, Mahmoud S., PhD, Brown, Linda M., DrPH, Ren, Zhaoxia, MD, PhD, Easterling, Thomas R., MD, Haas, David M., MD, MS, Haneline, Laura S., MD, Caritis, Steve N., MD, Venkataramanan, Raman, PhD, West, Holly, DHEd, D’Alton, Mary, MD, Hankins, Gary, MD

“…Background Preeclampsia complicates approximately 3–5% of pregnancies and remains a major cause of maternal and neonatal morbidity and mortality. It shares…”
Get full text

Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies by Chauhan, Suneet P., Rice, Madeline Murguia, Grobman, William A., Bailit, Jennifer, Reddy, Uma M., Wapner, Ronald J., Varner, Michael W., Thorp, John M., Leveno, Kenneth J., Caritis, Steve N., Prasad, Mona, Tita, Alan T. N., Saade, George, Sorokin, Yoram, Rouse, Dwight J., Tolosa, Jorge E.

“…OBJECTIVE:To compare morbidity among small-for-gestational-age (SGA; birth weight less than the 10th percentile for gestational age),…”
Get full text

Association Between Gestational Weight Gain and Perinatal Outcomes by Kominiarek, Michelle A., Saade, George, Mele, Lisa, Bailit, Jennifer, Reddy, Uma M., Wapner, Ronald J., Varner, Michael W., Thorp, John M., Caritis, Steve N., Prasad, Mona, Tita, Alan T.N., Sorokin, Yoram, Rouse, Dwight J., Blackwell, Sean C., Tolosa, Jorge E.

“…OBJECTIVE:To evaluate the association between gestational weight gain and maternal and neonatal outcomes in a large, geographically diverse cohort…”
Get full text

A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b) by Haas, David M., MD, MS, Parker, Corette B., DrPH, Wing, Deborah A., MD, Parry, Samuel, MD, Grobman, William A., MD, MBA, Mercer, Brian M., MD, Simhan, Hyagriv N., MD, Hoffman, Matthew K., MD, Silver, Robert M., MD, Wadhwa, Pathik, MD, PhD, Iams, Jay D., MD, Koch, Matthew A., MD, PhD, Caritis, Steve N., MD, Wapner, Ronald J., MD, Esplin, M. Sean, MD, Elovitz, Michal A., MD, Foroud, Tatiana, PhD, Peaceman, Alan M., MD, Saade, George R., MD, Willinger, Marian, PhD, Reddy, Uma M., MD, MPH

“…Objective The primary aim of the “Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be” is to determine maternal characteristics, which include…”
Get full text

Timing of Elective Repeat Cesarean Delivery at Term and Neonatal Outcomes by Tita, Alan T.N, Landon, Mark B, Spong, Catherine Y, Lai, Yinglei, Leveno, Kenneth J, Varner, Michael W, Moawad, Atef H, Caritis, Steve N, Meis, Paul J, Wapner, Ronald J, Sorokin, Yoram, Miodovnik, Menachem, Carpenter, Marshall, Peaceman, Alan M, O'Sullivan, Mary J, Sibai, Baha M, Langer, Oded, Thorp, John M, Ramin, Susan M, Mercer, Brian M

“…Among a large cohort of women with viable singleton pregnancies who underwent elective repeat cesarean sections, more than a third of deliveries were performed…”
Get full text

Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy by Bastian, Jaime R., PharmD, Chen, Huijun, Zhang, Hongfei, MSc, Rothenberger, Scott, PhD, Tarter, Ralph, PhD, English, Dennis, MD, Venkataramanan, Raman, PhD, Caritis, Steve N., MD

“…Background Buprenorphine is a Food and Drug Administration–approved maintenance therapy for opioid use disorders and is increasingly being used in pregnant…”
Get full text

A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy by Rouse, Dwight J, Hirtz, Deborah G, Thom, Elizabeth, Varner, Michael W, Spong, Catherine Y, Mercer, Brian M, Iams, Jay D, Wapner, Ronald J, Sorokin, Yoram, Alexander, James M, Harper, Margaret, Thorp, John M, Ramin, Susan M, Malone, Fergal D, Carpenter, Marshall, Miodovnik, Menachem, Moawad, Atef, O'Sullivan, Mary J, Peaceman, Alan M, Hankins, Gary D.V, Langer, Oded, Caritis, Steve N, Roberts, James M

“…In this multicenter, placebo-controlled, randomized trial of intravenous magnesium sulfate in women at imminent risk for delivery between 24 and 31 weeks of…”
Get full text

Serious maternal complications after early preterm delivery (24-33 weeks’ gestation) by Reddy, Uma M., MD, MPH, Rice, Madeline Murguia, PhD, Grobman, William A., MD, MBA, Bailit, Jennifer L., MD, MPH, Wapner, Ronald J., MD, Varner, Michael W., MD, Thorp, John M., MD, Leveno, Kenneth J., MD, Caritis, Steve N., MD, Prasad, Mona, DO, MPH, Tita, Alan T.N., MD, PhD, Saade, George R., MD, Sorokin, Yoram, MD, Rouse, Dwight J., MD, Blackwell, Sean C., MD, Tolosa, Jorge E., MD, MSCE

“…Objective We sought to describe the prevalence of serious maternal complications following early preterm birth by gestational age (GA), delivery route, and…”
Get full text

Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes by Rouse, Dwight J., MD, Weiner, Steven J., MS, Bloom, Steven L., MD, Varner, Michael W., MD, Spong, Catherine Y., MD, Ramin, Susan M., MD, Caritis, Steve N., MD, Peaceman, Alan M., MD, Sorokin, Yoram, MD, Sciscione, Anthony, DO, Carpenter, Marshall W., MD, Mercer, Brian M., MD, Thorp, John M., MD, Malone, Fergal D., MD, Harper, Margaret, MD, MS, Iams, Jay D., MD, Anderson, Garland D., MD

“…Objective The purpose of this study was to assess maternal and perinatal outcomes as a function of second-stage labor duration. Study Design We assessed…”
Get full text

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm by Grobman, William A., MD, MBA, Thom, Elizabeth A., PhD, Spong, Catherine Y., MD, Iams, Jay D., MD, Saade, George R., MD, Mercer, Brian M., MD, Tita, Alan T.N., MD, Rouse, Dwight J., MD, Sorokin, Yoram, MD, Wapner, Ronald J., MD, Leveno, Kenneth J., MD, Blackwell, Sean, MD, Esplin, M. Sean, MD, Tolosa, Jorge E., MD, MSCE, Thorp, John M., MD, Caritis, Steve N., MD, Van Dorsten, J. Peter, MD

“…Objective We sought to evaluate whether 17 alpha-hydroxyprogesterone caproate (17-OHP) reduces preterm birth (PTB) in nulliparous women with a midtrimester…”
Get full text

Uterine endoplasmic reticulum stress-unfolded protein response regulation of gestational length is caspase-3 and -7–dependent by Kyathanahalli, Chandrashekara, Organ, Kenna, Moreci, Rebecca S., Anamthathmakula, Prashanth, Hassan, Sonia S., Caritis, Steve N., Jeyasuria, Pancharatnam, Condon, Jennifer C.

“…We previously identified myometrial caspase-3 (CASP3) as a potential regulator of uterine quiescence. We also determined that during pregnancy, the functional…”
Get full text

Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery by Young, Omar M., MD, Shaik, Imam H., PhD, Twedt, Roxanna, MD, Binstock, Anna, MD, Althouse, Andrew D., PhD, Venkataramanan, Raman, PhD, Simhan, Hyagriv N., MD, MS, Wiesenfeld, Harold C., MD, CM, Caritis, Steve N., MD

“…Objective The objective of the study was to compare the pharmacokinetics of 2 g and 3 g doses of cefazolin when used for perioperative prophylaxis in obese…”
Get full text

Evaluation of delivery options for second-stage events by Bailit, Jennifer L., MD, MPH, Grobman, William A., MD, MBA, Rice, Madeline Murguia, PhD, Wapner, Ronald J., MD, Reddy, Uma M., MD, MPH, Varner, Michael W., MD, Thorp, John M., MD, Caritis, Steve N., MD, Iams, Jay D., MD, Saade, George, MD, Rouse, Dwight J., MD, Tolosa, Jorge E., MD, MSCE

“…Background Cesarean delivery in the second stage of labor is common, whereas the frequency of operative vaginal delivery has been declining. However, data…”
Get full text

Prothrombin Gene G20210A Mutation and Obstetric Complications by Silver, Robert M., Zhao, Yuan, Spong, Catherine Y., Sibai, Baha, Wendel, George, Wenstrom, Katharine, Samuels, Philip, Caritis, Steve N., Sorokin, Yoram, Miodovnik, Menachem, O'Sullivan, Mary J., Conway, Deborah, Wapner, Ronald J.

“…To estimate whether maternal carriage of the prothrombin gene G20210A mutation is associated with pregnancy loss, preeclampsia, placental abruption, or small…”
Get full text

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy by Tracy, Timothy S., Venkataramanan, Raman, Glover, Douglas D., Caritis, Steve N.

“…The purpose of this study was to determine whether drug metabolism (CYP1A2, CYP2D6 and CYP3A) activity varies in the pregnant state compared with the…”
Get full text

The Frequency and Complication Rates of Hysterectomy Accompanying Cesarean Delivery by Shellhaas, Cynthia S., Gilbert, Sharon, Landon, Mark B., Varner, Michael W., Leveno, Kenneth J., Hauth, John C., Spong, Catherine Y., Caritis, Steve N., Wapner, Ronald J., Sorokin, Yoram, Miodovnik, Menachem, O’Sullivan, Mary J., Sibai, Baha M., Langer, Oded, Gabbe, Steven G.

“…To estimate the frequency, indications, and complications of cesarean hysterectomy. This was a prospective, 2-year observational study at 13 academic medical…”
Get full text

Can differences in obstetric outcomes be explained by differences in the care provided? The MFMU Network APEX study by Grobman, William A., MD, MBA, Bailit, Jennifer L., MD, MPH, Rice, Madeline Murguia, PhD, Wapner, Ronald J., MD, Varner, Michael W., MD, Thorp, John M., MD, Leveno, Kenneth J., MD, Caritis, Steve N., MD, Iams, Jay D., MD, Tita, Alan T., MD, PhD, Saade, George, MD, Sorokin, Yoram, MD, Rouse, Dwight J., MD, Tolosa, Jorge E., MD, MSCE, Van Dorsten, J. Peter, MD

“…Objective The purpose of this study was to determine whether hospital differences in the frequency of adverse obstetric outcomes are related to differences in…”
Get full text

A Trial of 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Twins by Rouse, Dwight J, Caritis, Steve N, Peaceman, Alan M, Sciscione, Anthony, Thom, Elizabeth A, Spong, Catherine Y, Varner, Michael, Malone, Fergal, Iams, Jay D, Mercer, Brian M, Thorp, John, Sorokin, Yoram, Carpenter, Marshall, Lo, Julie, Ramin, Susan, Harper, Margaret, Anderson, Garland

“…Although 17 alpha-hydroxyprogesterone caproate (17P) has been shown to reduce the rate of recurrent preterm birth in singleton gestations, 17P did not reduce…”
Get full text

Timing of delivery and pregnancy outcomes in women with gestational diabetes by Feghali, Maisa N., MD, Caritis, Steve N., MD, Catov, Janet M., PhD, Scifres, Christina M., MD

“…Background Women with gestational diabetes mellitus (GDM) commonly undergo induction of labor (IOL) at term, but the risks and benefits of IOL are incompletely…”
Get full text